This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

| less than a minute read

This is a test

Test ISTATOY email

British drug manufacturer AstraZeneca, which has the licence for the Oxford University vaccine, is ramping up its global manufacturing capacity and has agreed to supply 100 million doses to the UK alone and possibly two billion globally - should it prove successful. Clinical trials were paused this week after a participant had a suspected adverse reaction in the UK.